ELOXX PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $27.5M | $6.1M |
| FY2015 | — | $12.2M | $3.3M |
| FY2016 | — | $4.6M | $810.8K |
| FY2017 | — | $871.2K | $33.2K |
| FY2018 | — | $42.9M | $48.6M |
| FY2019 | $10.5M | $36.2M | $22.5M |
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |
| FY2022 | $8.6M | $-10.7M | $19.2M |
| FY2023 | $1.6M | $-22.6M | $1.1M |